.png "Akums Begins Building Its First Overseas Plant in Zambia")
Akums Drugs & Pharmaceuticals Ltd. has commenced the construction of its first global manufacturing facility in Zambia, representing a significant advancement in its international expansion efforts. The ceremonial groundbreaking was initiated...
Swiss pharmaceutical company Novartis achieved its profit forecast for the third quarter on Tuesday, as robust growth from newer medications compensated for a significant decline in sales of its leading heart medication, Entresto, which is facing com
Philips has revealed an enhancement of its partnership with Nicolab, a prominent AI-based stroke management company, to improve stroke diagnosis and treatment in India. This partnership signifies a noteworthy step towards addressing one...
Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies that address emerging targets in oncology, is presenting preclinical data on RVU305
.jpeg "CDSCO Launches ONDLS to Track High-Risk Pharma Solvents")
After the discovery of diethylene glycol (DEG) in some cough syrups, the Central Drugs Standard Control Organisation (CDSCO) has launched a digitally monitored system on the Online National Drug Licensing System (ONDLS) portal.
IOL Chemicals & Pharmaceuticals Limited (IOLCP) is proud to announce an important milestone in their pharmaceutical division after being awarded a Certificate of Suitability
According to Minister for IT and Industries Duddilla Sridhar Babu, Telangana has set the lofty goal of bringing in Rs. 1 lakh crore in new investments in the life sciences sector by 2030 in order to create jobs for five lakh people
Sai Life Sciences Limited, among India's fastest growing Contract Research, Development and Manufacturing Organizations (CRDMO), is announcing the ground breaking of a CMC Process R&D Center at its integrated R&D campus in Hyderabad...
India released a list of registered interested parties on Monday, advancing an anti-dumping inquiry into imports of ethambutol hydrochloride, an active pharmaceutical ingredient used in anti-tuberculosis medications, from China and Thailand
GSK has signed a global exclusive deal with Syndivia - a privately-held biotech dedicated to developing next-generation antibody-drug conjugates (ADCs) - for the advancement and commercialization of a preclinical ADC for patients with metastatic...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")